Inventor
KOLKHOF PETER
DE47 patents
⚠️ This page may combine multiple inventors who share the name “KOLKHOF PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
14 patentsUS9988367B2Jun 5, 2018
Amide-substituted pyridinyltriazole derivatives and uses thereof
Bayer Pharma AG5 citations83
US9771352B2Sep 26, 2017
Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
Bayer Pharma AG8 citations82
US10525041B2Jan 7, 2020
Fluoroalkyl-substituted aryltriazole derivatives and uses thereof
Bayer Pharma AG3 citations72
US10472348B2Nov 12, 2019
Amide-substituted pyridinyltriazole derivatives and uses thereof
Bayer Pharma AG3 citations72
US10918639B2Feb 16, 2021
Combination containing SGC stimulators and mineralocorticoid receptor antagonists
Bayer Pharma AG3 citations71
US10815205B2Oct 27, 2020
Amide-substituted phenyltriazole derivatives and uses thereof
Bayer Pharma AG2 citations71
US11684621B2Jun 27, 2023
Combination containing sGC stimulators and mineralocorticoid receptor antagonists
Bayer Pharma AG0 citations61
US11331308B2May 17, 2022
Combination containing sGC activators and mineralocorticoid receptor antagonists
Bayer Pharma AG1 citations61
US11091463B2Aug 17, 2021
Amide-substituted pyridinyltriazole derivatives and uses thereof
Bayer Pharma AG0 citations61
US11331314B2May 17, 2022
Amine substituted triazole derivatives and uses thereof
Bayer Pharma AG0 citations51
US11230540B2Jan 25, 2022
Substituted triazole derivatives and uses thereof
Bayer Pharma AG0 citations51
US10927098B2Feb 23, 2021
Hydroxyalkyl-substituted triazole derivatives and uses thereof
Bayer Pharma AG0 citations51
US11149023B2Oct 19, 2021
Substituted triazole derivatives and uses thereof
Bayer Pharma AG0 citations50
US10800746B2Oct 13, 2020
Oxoalkyl-substituted phenyltriazole derivatives and uses thereof
Bayer Pharma AG0 citations50
BAYER AG
5 patentsUS6114341ASep 5, 2000
Pyrimido[1,2-a]indoles
BAYER AG19 citations84
US10526314B2Jan 7, 2020
Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereof
BAYER AG3 citations72
US11298367B2Apr 12, 2022
Prodrugs of substituted triazole derivatives and uses thereof
BAYER AG0 citations60
US11439628B2Sep 13, 2022
Use of non-steroidal mineralocorticoid receptor antagonists alone or in combination for the treatment of muscular or neuromuscular diseases
BAYER AG0 citations55
US11173151B2Nov 16, 2021
Substituted triazole derivatives and uses thereof
BAYER AG0 citations51
THEDE KAI
4 patentsUS8653111B2Feb 18, 2014
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
THEDE KAI7 citations83
US8389520B2Mar 5, 2013
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
THEDE KAI8 citations83
US8524699B2Sep 3, 2013
Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors
THEDE KAI6 citations72
US8609698B2Dec 17, 2013
Substituted dipyridyl-dihydropyrazolones and use thereof
THEDE KAI4 citations61
BAYER IP GMBH
4 patentsUS9687476B2Jun 27, 2017
Bisaryl-bonded aryltriazolones and use thereof
BAYER IP GMBH8 citations82
US9168249B2Oct 27, 2015
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
BAYER IP GMBH1 citations61
US8987261B2Mar 24, 2015
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
BAYER IP GMBH1 citations61
US9051316B2Jun 9, 2015
Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use
BAYER IP GMBH3 citations60
BAERFACKER LARS
2 patentsFLAMME INGO
2 patentsUS8252817B2Aug 28, 2012
Dipyridyl-dihydropyrazolones and their use
FLAMME INGO7 citations81
US9085572B2Jul 21, 2015
4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases
FLAMME INGO1 citations46